Daytrana Duration-Of-Use Data Suggest Potential For Individualized Dosing
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase IIIb study of methylphenidate patch shows efficacy when used for four- and six-hour periods, Shire says.